Lv7
4178 积分 2022-07-12 加入
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
11天前
已完结
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice
11天前
已完结
Biomarkers of increased bleeding risk in patients with atrial fibrillation on oral anticoagulation: a narrative review
11天前
已完结
Comments on the 2024 ESC guidelines for the management of atrial fibrillation
11天前
已关闭
Biomarkers in atrial fibrillation: a clinical review
11天前
已完结
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
11天前
已完结
Stroke prevention in atrial fibrillation
11天前
已完结
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
11天前
已完结
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
11天前
已完结
Stroke prevention strategies in high-risk patients with atrial fibrillation
11天前
已完结
皖公网安备34019202002308
